Giuliani Maria, Parrilli Ermenegilda, Sannino Filomena, Apuzzo Gennaro Antonio, Marino Gennaro, Tutino Maria Luisa
Dipartimento di Scienze Chimiche, Università di Napoli "Federico II", Via Cinthia, 4, 80126, Naples, Italy,
Appl Microbiol Biotechnol. 2014 Jun;98(11):4887-95. doi: 10.1007/s00253-014-5582-1. Epub 2014 Feb 18.
Recombinant protein production in cold-adapted bacteria has proved to be a valuable option to overcome solubility concerns often came up in conventional expression hosts. ScFvs are examples of "difficult proteins" due to their tendency to form inclusion bodies when expressed in Escherichia coli. In this paper, the recombinant production of a single-chain antibody (ScFvOx) in the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC125 is reported. The expression vector for the ScFvOx production was designed to address the recombinant protein in the periplasmic space and to allow the formation of the antibody disulphide bonds. For periplasmic export, two different export mechanisms were evaluated. By combining the genetic tools available for recombinant protein expression in psychrophilic hosts with an ad hoc medium and fermentation modality and optimised expression conditions at low temperatures, we obtained the highest yield of soluble and epitope-binding ScFvOx reported so far by conventional prokaryotic expression. The observed proficiency of the Antarctic bacterium to produce recombinant antibody fragments was related to the unusually high number of genes encoding peptidyl prolyl cis-trans isomerases found in P. haloplanktis TAC125 genome, making this bacterium the host of choice for the recombinant production of this protein class.
事实证明,在低温适应细菌中生产重组蛋白是克服传统表达宿主中经常出现的溶解性问题的一种有价值的选择。单链抗体片段(ScFv)由于在大肠杆菌中表达时易于形成包涵体,属于“难表达蛋白”。本文报道了在嗜冷细菌嗜盐栖假交替单胞菌TAC125中重组生产单链抗体(ScFvOx)。用于生产ScFvOx的表达载体设计用于将重组蛋白定位到周质空间,并允许抗体二硫键的形成。对于周质输出,评估了两种不同的输出机制。通过将嗜冷宿主中可用于重组蛋白表达的遗传工具与特定培养基、发酵方式以及低温下优化的表达条件相结合,我们获得了迄今为止通过传统原核表达报道的可溶性和具有表位结合能力的ScFvOx的最高产量。观察到的南极细菌生产重组抗体片段的能力与嗜盐栖假交替单胞菌TAC125基因组中编码肽基脯氨酰顺反异构酶的基因数量异常之多有关,这使得该细菌成为重组生产此类蛋白的首选宿主。